Immunoassay using an amplified cyclic detection system

• US 4,446,231 A
• Filed: 10/01/1981
• Issued: 05/01/1984
• Est. Priority Date: 10/03/1979
• Status: Expired due to Term

• Current Assignee: Colin H. Self
• Original Assignee: Colin H. Self
• Inventors: Self, Colin H.
• Primary Examiner(s): Wiseman, Thomas G.
• Assistant Examiner(s): Tarcza, John Edward
• Application Number:
  US06/307,600
• Time in Patent Office: 943 Days
• Field of Search: 435/4, 435/7, 435/188, 435/810, 435/26, 424/8, 424/12, 436/536, 436/537
• US Class Current: 435/7.91
• CPC Class Codes: C12Q 1/48 involving transferase
• CPC Class Codes: C12Q 1/50 involving creatine phosphokinase
• CPC Class Codes: G01N 33/53 Immunoassay; Biospecific binding assay; Materials therefor
• CPC Class Codes: G01N 33/581 with enzyme label (including co-enzymes, co-factors, enzyme inhibitors or substrates)
• CPC Class Codes: Y10S 435/81 Packaged device or kit
• CPC Class Codes: Y10S 435/966 involving an enzyme system with high turnover rate or complement magnified assay, e.g. multi-enzyme systems

Abstract

An immunoassay is disclosed where the label is an enzyme which converts a precursor into a cycling factor which in turn is interconverted in a cycling detection system. The detection system is amplified by the enzyme label constantly increasing the amount of cycling factors in the system. The system of NADP to NAD with NAD cycling to NADH and back is preferred.

Claims

1. In a method for determining a member of a ligand and receptor pair which comprises an assay wherein:

(a) a sample of a first member of the ligand and receptor pair is contacted with a matrix bound second member of the pair whereby said first member becomes bound to said second member;

(b) the thus produced matrix bound first member is contacted with a conjugate which binds specifically to the matrix bound first member which conjugate comprises a phosphatase whereby said phosphatase is bound to the matrix and

(c) the matrix bound and unbound conjugate are separated and the matrix bound or the unbound conjugate is assayed;

the improvement which comprises;

(d) contacting the conjugate to be assayed with a precursor for NAD whereby NAD is produced, and

(e) contacting the thus produced NAD with the components of a secondary system which is activated by the NAD, said secondary system comprising a cyclic chemical reaction which interconverts NAD and NADH, neither of which is present until the production of NAD by the conjugate, and which secondary system maintains the increase in concentration of NAD produced by the conjugate and produces a determinable change, said components of the cyclic chemical reaction being present in sufficient quantity to maintain the cyclic chemical reaction and produce determinable product at each turn of the cycle whereby amplification of the determinable change occurs.

2. The improvement according to claim 1 in which the determinable change results from the production of a determinable product.

3. The improvement according to claim 2 wherein the conjugate is a conjugate of an alkaline phosphatase.

4. The improvement according to claim 2 wherein the conjugate is a conjugate of an acide phosphatase.

5. The improvement according to claim 2 wherein the cyclic chemical reaction is allowed to proceed at pH 8-10.5.

6. The improvement according to claim 5 wherein the pH is maintained by the presence of a buffer.

7. The improvement according to claim 2 wherein the NAD is produced from NADP.

8. The improvement according to claim 2 wherein the assay is carried out at ambient temperature.

9. The improvement according to claim 2 wherein the phosphatase is bound to the ligand or receptor in the conjugate by reaction with a bifunctional conjugating reagent.

10. The improvement according to claim 1 wherein the immunoassay is for the detection of an antigen.

11. The improvement according to claim 1 wherein the immunoassay is for the detection of an antibody.

12. The improvement according to claim 1 wherein the cyclic chemical reaction which interconverts NAD and NADH comprises one enzyme catalyzed reaction and one non-enzyme catalyzed reaction.

13. The improvement according to claim 12 wherein NAD is converted to NADH by a dehydrogenase.

14. The improvement according to claim 13 wherein the dehydrogenase is alcohol dehydrogenase.

15. The improvement according to claim 14 wherein the conversion of NAD to NADH accompanies reduction of tetrazolium compound whereby a colour change is produced.

16. The improvement according to claim 13 wherein the conversion of NADH to NAD accompanies reduction of a tetrazolium compound whereby a colour change is produced.

17. The improvement according to claim 1 wherein the cyclic reaction comprises two enzyme catalyzed reactions.

18. The improvement according to claim 17 wherein NAD is converted to NADH by a dehydrogenase.

19. The improvement according to claim 18 wherein the dehydrogenase is alcohol dehydrogenase.

20. The improvement according to claim 19 wherein the conversion of NAD to NADH accompanies reduction of tetrazolium compound whereby a colour change is produced.

21. The improvement according to claim 18 wherein the conversion of NAD to NADH accompanies reduction of a tetrazolium compound whereby a colour change is produced.